Unjali P Gujral1, Eric Vittinghoff1, Morgana Mongraw-Chaffin1, Dhananjay Vaidya1, Namratha R Kandula1, Matthew Allison1, Jeffrey Carr1, Kiang Liu1, K M Venkat Narayan1, Alka M Kanaya1. 1. From Emory University, Atlanta, Georgia; University of California, San Francisco, San Francisco, and University of California, San Diego, San Diego, California; Wake Forest School of Medicine, Winston-Salem, North Carolina; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, and Northwestern University, Evanston, Illinois; and Vanderbilt University, Nashville, Tennessee.
Abstract
BACKGROUND: The relationship between body weight and cardiometabolic disease may vary substantially by race/ethnicity. OBJECTIVE: To determine the prevalence and correlates of the phenotype of metabolic abnormality but normal weight (MAN) for 5 racial/ethnic groups. DESIGN: Cross-sectional analysis. SETTING: 2 community-based cohorts. PARTICIPANTS: 2622 white, 803 Chinese American, 1893 African American, and 1496 Hispanic persons from MESA (Multi-Ethnic Study of Atherosclerosis) and 803 South Asian participants in the MASALA (Mediators of Atherosclerosis in South Asians Living in America) study. MEASUREMENTS: Prevalence of 2 or more cardiometabolic abnormalities (high fasting glucose, low high-density lipoprotein cholesterol, and high triglyceride levels and hypertension) among normal-weight participants was estimated. Correlates of MAN were assessed by using log-binomial models. RESULTS: Among normal-weight participants (n = 846 whites, 323 Chinese Americans, 334 African Americans, 252 Hispanics, and 195 South Asians), the prevalence of MAN was 21.0% (95% CI, 18.4% to 23.9%) in whites, 32.2% (CI, 27.3% to 37.4%) in Chinese Americans, 31.1% (CI, 26.3% to 36.3%) in African Americans, 38.5% (CI, 32.6% to 44.6%) in Hispanics, and 43.6% (CI, 36.8% to 50.6%) in South Asians. Adjustment for demographic, behavioral, and ectopic body fat measures did not explain racial/ethnic differences. After adjustment for age, sex, and race/ethnicity-body mass index (BMI) interaction, for the equivalent MAN prevalence at a BMI of 25.0 kg/m2 in whites, the corresponding BMI values were 22.9 kg/m2 (CI, 19.5 to 26.3 kg/m2) in African Americans, 21.5 kg/m2 (CI, 18.5 to 24.5 kg/m2) in Hispanics, 20.9 kg/m2 (CI, 19.7 to 22.1 kg/m2) in Chinese Americans, and 19.6 kg/m2 (CI, 17.2 to 22.0 kg/m2) in South Asians. LIMITATION: Cross-sectional study design and lack of harmonized dietary data between studies. CONCLUSION: Compared with whites, all racial/ethnic minority groups had a statistically significantly higher prevalence of MAN, which was not explained by demographic, behavioral, or ectopic fat measures. Using a BMI criterion for overweight to screen for cardiometabolic risk may result in a large proportion of racial/ethnic minority groups being overlooked. PRIMARY FUNDING SOURCE: National Institutes of Health.
BACKGROUND: The relationship between body weight and cardiometabolic disease may vary substantially by race/ethnicity. OBJECTIVE: To determine the prevalence and correlates of the phenotype of metabolic abnormality but normal weight (MAN) for 5 racial/ethnic groups. DESIGN: Cross-sectional analysis. SETTING: 2 community-based cohorts. PARTICIPANTS: 2622 white, 803 Chinese American, 1893 African American, and 1496 Hispanic persons from MESA (Multi-Ethnic Study of Atherosclerosis) and 803 South Asian participants in the MASALA (Mediators of Atherosclerosis in South Asians Living in America) study. MEASUREMENTS: Prevalence of 2 or more cardiometabolic abnormalities (high fasting glucose, low high-density lipoprotein cholesterol, and high triglyceride levels and hypertension) among normal-weight participants was estimated. Correlates of MAN were assessed by using log-binomial models. RESULTS: Among normal-weight participants (n = 846 whites, 323 Chinese Americans, 334 African Americans, 252 Hispanics, and 195 South Asians), the prevalence of MAN was 21.0% (95% CI, 18.4% to 23.9%) in whites, 32.2% (CI, 27.3% to 37.4%) in Chinese Americans, 31.1% (CI, 26.3% to 36.3%) in African Americans, 38.5% (CI, 32.6% to 44.6%) in Hispanics, and 43.6% (CI, 36.8% to 50.6%) in South Asians. Adjustment for demographic, behavioral, and ectopic body fat measures did not explain racial/ethnic differences. After adjustment for age, sex, and race/ethnicity-body mass index (BMI) interaction, for the equivalent MAN prevalence at a BMI of 25.0 kg/m2 in whites, the corresponding BMI values were 22.9 kg/m2 (CI, 19.5 to 26.3 kg/m2) in African Americans, 21.5 kg/m2 (CI, 18.5 to 24.5 kg/m2) in Hispanics, 20.9 kg/m2 (CI, 19.7 to 22.1 kg/m2) in Chinese Americans, and 19.6 kg/m2 (CI, 17.2 to 22.0 kg/m2) in South Asians. LIMITATION: Cross-sectional study design and lack of harmonized dietary data between studies. CONCLUSION: Compared with whites, all racial/ethnic minority groups had a statistically significantly higher prevalence of MAN, which was not explained by demographic, behavioral, or ectopic fat measures. Using a BMI criterion for overweight to screen for cardiometabolic risk may result in a large proportion of racial/ethnic minority groups being overlooked. PRIMARY FUNDING SOURCE: National Institutes of Health.
Authors: Fahad Razak; Sonia S Anand; Harry Shannon; Vladimir Vuksan; Bonnie Davis; Ruby Jacobs; Koon K Teo; Matthew McQueen; Salim Yusuf Journal: Circulation Date: 2007-04-09 Impact factor: 29.690
Authors: Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir Journal: Mayo Clin Proc Date: 2014-03-07 Impact factor: 7.616
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: Michael V Holmes; Leslie A Lange; Tom Palmer; Matthew B Lanktree; Kari E North; Berta Almoguera; Sarah Buxbaum; Hareesh R Chandrupatla; Clara C Elbers; Yiran Guo; Ron C Hoogeveen; Jin Li; Yun R Li; Daniel I Swerdlow; Mary Cushman; Tom S Price; Sean P Curtis; Myriam Fornage; Hakon Hakonarson; Sanjay R Patel; Susan Redline; David S Siscovick; Michael Y Tsai; James G Wilson; Yvonne T van der Schouw; Garret A FitzGerald; Aroon D Hingorani; Juan P Casas; Paul I W de Bakker; Stephen S Rich; Eric E Schadt; Folkert W Asselbergs; Alex P Reiner; Brendan J Keating Journal: Am J Hum Genet Date: 2014-01-23 Impact factor: 11.025
Authors: Penny Gordon-Larsen; Linda S Adair; James B Meigs; Elizabeth Mayer-Davis; Amy Herring; Sheng-kai Yan; Bing Zhang; Shufa Du; Barry M Popkin Journal: Obesity (Silver Spring) Date: 2013-01 Impact factor: 5.002
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Lisa R Staimez; Mohan Deepa; Mohammed K Ali; Viswanathan Mohan; Robert L Hanson; K M Venkat Narayan Journal: Diabetes Metab Res Rev Date: 2019-07-29 Impact factor: 4.876
Authors: Neil M Iyengar; I-Chun Chen; Xi K Zhou; Dilip D Giri; Domenick J Falcone; Lisle A Winston; Hanhan Wang; Samantha Williams; Yen-Shen Lu; Tsu-Hsin Hsueh; Ann-Lii Cheng; Clifford A Hudis; Ching-Hung Lin; Andrew J Dannenberg Journal: Cancer Prev Res (Phila) Date: 2017-12-08
Authors: Justin B Echouffo-Tcheugui; Meghan I Short; Vanessa Xanthakis; Patrick Field; Todd R Sponholtz; Martin G Larson; Ramachandran S Vasan Journal: J Clin Endocrinol Metab Date: 2019-03-01 Impact factor: 5.958
Authors: Nicola Lancki; Juned Siddique; John A Schneider; Alka M Kanaya; Kayo Fujimoto; Swapna S Dave; Ankita Puri-Taneja; Namratha R Kandula Journal: Obes Med Date: 2018-06-30
Authors: Donghee Kim; Won Kim; Sae Kyung Joo; Jimin Han; Jung Ho Kim; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed Journal: J Gastroenterol Date: 2019-09-18 Impact factor: 7.527